Patton Fund Management’s Quest Diagnostics DGX Stock Holding History

Patton Fund Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-7,459	Closed	-$1.58M	–	90
2026 Q2	$1.58M	Sell	7,459 -4,314	-37%	-$847K	0.34%	81
2026 Q1	$2.31M	Sell	11,773 -20,266	-63%	-$3.94M	0.39%	89
2025 Q4	$5.56M	Buy	32,039 +30,772	+2,429%	+$5.6M	0.75%	61
2025 Q3	$241K	Hold	1,267	–	–	0.04%	303
2025 Q2	$228K	Buy	+1,267	New	+$220K	0.05%	327
2023 Q1	–	Sell	-1,309	Closed	-$205K	–	124
2022 Q4	$205K	Buy	+1,309	New	+$188K	0.06%	165
2020 Q4	–	Sell	-7,473	Closed	-$856K	–	80
2020 Q3	$856K	Sell	7,473 -360	-5%	-$42.5K	0.46%	71
2020 Q2	$893K	Buy	+7,833	New	+$831K	0.52%	58

Other funds holding DGX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Patton Fund Management's DGX Position: Q3 2026 in Review

Patton Fund Management sold out of Quest Diagnostics (DGX) in Q3 2026, closing a stake of 7,459 shares — an estimated $1.58M sold.

Patton Fund Management first reported a position in DGX in Q2 2020 and held it in 8 quarters. The position peaked at $5.56M in Q4 2025. 605 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

Patton Fund Management reported no remaining Quest Diagnostics position as of Q3 2026 after selling out during the quarter.
Patton Fund Management sold 7,459 Quest Diagnostics shares in Q3 2026, an estimated $1.58M.
Patton Fund Management first reported a position in Quest Diagnostics in Q2 2020 and held it in 8 quarters.
Patton Fund Management's Quest Diagnostics position peaked at $5.56M in Q4 2025.
605 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Patton Fund Management's 13F filing for Q3 2026, filed 13 Oct 2026.